Live Breaking News & Updates on Gene Therapy Manufacturing

Stay updated with breaking news from Gene therapy manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cell and Gene Therapy Manufacturing Market is projected to increase at a CAGR 29% from 2023 to 2033

The global cell and gene therapy manufacturing market is worth US$ 19.3 Billion as of now and expected to reach US$ 240 Billion by the year 2033 at a staggering CAGR of 29% between 2023 and 2033.The changing landscape of treating chronic ailments through advanced therapies is the key factor driving the cell and gene. ....

United States , New York , United Kingdom , Miltenyi Biotec , Lonza Biotherapies , Samsung Biologics , Brammer Bio , Masthercell Global Inc , Allogene Therapeutics Inc , Boehringer Ingelheim , Thermo Fisher , Hitachi Chemical Co Ltd , Merck Kga , Takara Bio Inc , Bluebird Bio Inc , American Cancer Society , Roche Ltd , Market Insights Inc , Merck Kgaa , Biocardia Inc , Catalent Inc , Key Companies , Greater New York Chamber , Acute Respiratory Distress , Market Insights , Gene Therapy Manufacturing ,